BCR and diffuse large B-cell lymphoma: Notably, these systems have reinforced the central role of B-cell receptor (BCR) signaling as a key determinant of diffuse large B-cell lymphoma (DLBCL) pathobiology, providing experimental evidence that microenvironmental and immune interactions directly modulate intracellular oncogenic signaling [43].